Blood glucose and subsequent cardiovascular disease: Update of a meta-analysis

Current Medical Research and Opinion

Volumn 27, Issue 11, 2011, Pages 2155-2163

  Einarson, Thomas R ^a   MacHado, Mrcio ^b   Henk Hemels, Michiel Eric ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Janssen Cilag   (Denmark)

^d NOVO NORDISK A S   (Denmark)

Author keywords

Blood glucose; Cardiac death; Cardiovascular death; Cardiovascular events; Cerebrovascular mortality; Death; Meta analysis; Mortality; Myocardial infarction; Prospective studies; Stroke

Indexed keywords

GLUCOSE;

ARTICLE; CARDIOVASCULAR DISEASE; COCHRANE LIBRARY; CONSENSUS; DEATH; DIABETES MELLITUS; EMBASE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; SYSTEMATIC REVIEW;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; FASTING; FEMALE; HUMANS; MALE; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; STROKE;

EID: 80054684633     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.626760     Document Type: Article

References (53)

1. Juutilainen A, Lehto S, Rönnemaa T, et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 2008;31:714-19
2. Turner R, Cull C, Holmann R. UKPDS 17: a 9 year update on Type 2 diabetes. Ann Intern Med 1996;124:136-45
3. Hanefeld M, Temelkova-Kurktschiev T. Control of post-prandial hyperglycemia-an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr Metab Cardiovasc Dis 2002;12:98-107 (Pubitemid 135712752)
4. Hanefeld M, Schulze J, Fischer S, et al. The Diabetes Intervention Study (DIS): a cooperative multi-intervention trial with newly manifested type II diabetics: preliminary results. Monogr Atheroscler 1985;13:98-103
5. Cavalot F, Petrelli A, Traversa M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Endocrinol Metab 2006;91:813-19 (Pubitemid 43357744)
6. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 2001;44:2107-14 (Pubitemid 34015463)
7. DECODE. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 1999;354:617-21
8. Coutinho M, Wong Y, Gerstein H, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-40 (Pubitemid 29056916)
9. Kilpatrick E, Rigby A, Atkin S. Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 2008;51:365-71
10. Jackson C, Yudkin J, Forrest R. A comparison of the relationships of the glucose tolerance test and the glycated hemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabetes Res Clin Pract 1992;17:111-23
11. de Vegt F, Dekker J, Ruhe H, et al. Hyperglycaemia is associated with allcause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999;42:926-31 (Pubitemid 29369599)
12. O'Keefe J, Bell D. Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007;100:899-904 (Pubitemid 47268287)
13. Bell D, O'Keefe J, Jellinger P. Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events? Endocr Pract 2008;14:112-24
14. Blake D, Meigs J, Muller D, et al. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: Results from the Baltimore Longitudinal Study on Aging. Diabetes 2004;53:2095-100 (Pubitemid 38970760)
15. Charpentier G, Riveline J-P, Dardari D, et al. Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated? Drugs 2006;66:273-6
16. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Geneva: WHO Document Production Services, 2006
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl 1):S43-8
18. Cochran W. The combination of estimates from different experiments. Biometrics 1954;10:101-29
19. Folsom A, Liao F, Szklo M, et al. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1997;20:935-42 (Pubitemid 27224942)
20. Barr E, Zimmet P, Welborn T, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance. The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007;16:151-7 (Pubitemid 47057520)
21. Yarnell J, Pickering J, Elwood P, et al. Does non-diabetic hyperglycemia predict future IHD? Evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 1994;47:383-8 (Pubitemid 24123686)
22. Schroll M, Hagerup L. Relationship of fasting blood glucose to prevalence of ECG abnormalities and 10 yr risk of mortality from cardiovascular diseases in men born in 1914: from the Glostrup Population Studies. J Chron Dis 1979;32:699-707 (Pubitemid 10168147)
23. Ohlson L, Svarsudd K, Welin L, et al. Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality: a 17-year follow-up study of men born in 1913. Diabet Med 1986;8:33-7 (Pubitemid 16180236)
24. PyöräläK, Savolainen E, Lehtovirta E, et al. Glucose tolerance and coronary heart disease: Helsinki Policemen Study. J Chron Dis 1979;32:729-45 (Pubitemid 10168150)
25. Shaten B, Kuller L, Neaton J. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. Prev Med 1991;20:655-69
26. Wen C, Cheng T, Tsai S, et al. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 2005;28:2756-61 (Pubitemid 43958385)
27. Bjørnholt J, Nitter-Hauge S, Erikssen G, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Diabetes Care 1999;22:45-9
28. Kim S, Chunawala L, Linde R, et al. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice. J Am Coll Cardiol 2006;48:293-7
29. Scheidt-Nave C, Barrett-Connor E, et al. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol 1991;133:565-76
30. Pankow J, Kwan D, Duncan B, et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007;30:325-31 (Pubitemid 46198338)
31. Da Silva A, Widmer L, Ziegler H, et al. The Basle Longitudinal Study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality. J Chron Dis 1979;32:797-803 (Pubitemid 10168157)
32. Qiao Q, Eriksson J, Jousilahti P, et al. Predicted properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 2003;26:2910-14 (Pubitemid 37205567)
33. Grabauskas V. Glucose intolerance as contributor to noncommunicable disease morbidity and mortality: WHO Integrated Program for Community Health in Noncommunicable Diseases. Diabetes Care 1988;11:253-7
34. Kuusisto J, Mykkanen L, PyöräläK, et al. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994;43:960-7 (Pubitemid 24230698)
35. Knowler W, Sasaki A, Melander A, et al. Glucose tolerance and mortality, including a substudy of tolbutamide treatment. Diabetologia 1997;40:680-6 (Pubitemid 27288114)
36. Tuomilehto J, Schranz A, Aldana D, et al. The effect of diabetes and impaired glucose tolerance on mortality in Malta. Diabet Med 1994;11:170-6 (Pubitemid 24124923)
37. Saydah S, Varas C, Miret M, et al. Postchallenge hyperglycemia and mortality in a national sample of US adults. Diabetes Care 2001;24:1397-402 (Pubitemid 33716427)
38. Balkau B, PyöräläM, Shipley M, et al. High blood glucose concentration is a risk factor for middle-aged non-diabetic men. Diabetes Care 1998;21:360-7
39. Stenga° rd J, Tuomilehto J, Pekkanen J, et al. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of The Seven Countries Study. Diabetologia 1992;35:760-5
40. Ma S, Cutter J, Tan C, et al. Associations of diabetes mellitus and ethnicity with mortality in a multiethnic Asian population: data from the 1992 Singapore National Health Survey. Am J Epidemiol 2003;158:543-52 (Pubitemid 37093230)
41. Stamler R, Stamler J, Lindberg H, et al. Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago. J Chron Dis 1979;32:805-15 (Pubitemid 10168158)
42. Brunner E, Fuller J, Shipley M, et al. Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 2006;29:26-31 (Pubitemid 44033426)
43. Stenhouse N, Murphy B, Welborn T. Busselton Population Study: risk associated with asymtomatic hyperglycemia. J Chron Dis 1979;32:693-8 (Pubitemid 10168146)
44. Orencia A, Daviglus M, Dyer A, et al. One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol 1997;50:1369-76 (Pubitemid 28034990)
45. Donahue R, Abbott R, Reed D, et al. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: the Honolulu Heart Program. Diabetes 1987;36:689-92 (Pubitemid 17141106)
46. Vaccaro O, Ruth K, Stamler J. Relationship of postload plasma glucose to mortality with 19-yr follow-up: comparison of one versus two plasma glucose levels in the Chicago Peoples Gas Company Study. Diabetes Care 1992;15:1328-34
47. Reunanen A, PyöräläK, Aromaa A, et al. Glucose tolerance and coronary heart disease in middle-aged Finnish men: Social Insurance Institution's Coronary Heart Disease Study. J Chron Dis 1979;32:747-58 (Pubitemid 10168151)
48. Perry I, Wannamethee S, Whincup P, Shaper A. Asymptomatic hyperglycaemia and major ischemic heart disease events in Britain. J Epidemiol Community Health 1994;48:538-42
49. Kadowaki S, Okamura T, Hozawa A, et al. Relationship of elevated casual blood glucose level with coronary heart disease, cardiovascular disease and all-cause mortality in a representative sample of the Japanese population. NIPPON DATA80. Diabetologia 2008;51:575-82
50. Lund Haheim L, Holme I, Hjermann I, Leren P. Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects: 18-year follow-up of the Oslo Study. Stroke 1995;26:774-7
51. Cruz-Vidal M, Garcia-Palmieri M, Costas R, et al. Abnormal blood glucose and coronary heart disease: the Puerto Rico Heart Health program. Diabetes Care 1983;6:556-61
52. Hawthorne V, Gilmour W. Relationship of glucose to prevalence of ECG abnormalities at baseline and to 6-yr mortality in Scottish males aged 45-64 yr. J Chron Dis 1979;32:787-96 (Pubitemid 10168156)
53. Hart C, Hole D, Davey Smith G. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley Study in Scotland. Stroke 1999;30:1999-2007 (Pubitemid 29473240)